GlaxoSmithKline still has questions to answer over bribery case in China

It’s good news that Mark Reilly is not going to prison but what of GSK chief executive Sir Andrew Witty’s ethical agenda?

GlaxoSmithKline has made a grovelling apology to "the Chinese government and the Chinese people" and will pay a fine of almost £300m for bribing doctors.

Humiliating stuff, especially for a FTSE 100 company whose chief executive, Sir Andrew Witty, preaches an ethical agenda.

Continue reading…
Pharmaceuticals industry | The Guardian

Pharmaceutical Stocks


© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us